2 strong ASX mid cap shares to buy

Pro Medicus Limited (ASX:PME) and this ASX mid cap share could be the ones to buy for the long term. Here’s why they are highly rated…
The post 2 strong ASX mid cap shares to buy appeared first on The Motley Fool Australia. –

A business man open his shirt to reveal a superhero style $ on his chest, indicating a strong ASX share price

If you are interested in investing in some promising mid cap shares, then you may want to take a look at the two listed below.

Both have a lot of potential and have been rated as buys recently. Here’s what you need to know about these ASX shares:

Collins Foods Ltd (ASX: CKF)

The first mid cap ASX share to look at is Collins Foods. It is one of Australia’s leading operators of quick service restaurants.

Collins Foods has a growing KFC network across Australia and also in the under-penetrated European market. In addition to this, the company has been successfully rolling out the Taco Bell brand across Australia.

It has been a very positive performer during the pandemic. For example, during the first half of FY 2021, Collins Foods reported an 11.3% increase in revenue to $499.6 million. Things were even better on the bottom line, with underlying net profit after tax coming in 15.1% higher at $27.5 million.

Positively, the company looks well-placed for growth over the next decade thanks to its store expansion opportunities. It also has the option of adding to its portfolio of brands through acquisitions, developments, or agreements. 

UBS believes the company is well-positioned to continue its strong performance over the medium term. In light of this, the broker currently has a buy rating and $11.65 price target on Collins Foods’ shares.

Pro Medicus Limited (ASX: PME)

Another mid cap ASX share to consider is Pro Medicus. It is a healthcare technology company providing healthcare institutions with high quality radiology information systems (RIS), picture archiving and communication systems (PACS), and advanced visualisation solutions to healthcare organisations globally.

A number of the largest healthcare institutions in the world have been adopting its technology on long term contracts in recent years. This has continued in FY 2021, with the company reporting a series of major contract wins.

As a result, Pro Medicus looks well-positioned to continue its strong earnings growth for a long time to come.

One broker that expects this to be the case is Goldman Sachs. It has been pleased with its performance in FY 2021 and recently upgraded Pro Medicus’ shares to a buy rating with a $53.80 price target.

Where to invest $1,000 right now

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

See The 5 Stocks

*Returns as of February 15th 2021

More reading

James Mickleboro owns shares of Collins Foods Limited. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and recommends Pro Medicus Ltd. The Motley Fool Australia has recommended Collins Foods Limited and Pro Medicus Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post 2 strong ASX mid cap shares to buy appeared first on The Motley Fool Australia.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!